» Articles » PMID: 36995477

Evaluation of Coronary Disease Among Patients Undergoing Transcatheter Aortic Valve Implantation: Propensity Score Matching Analysis

Overview
Date 2023 Mar 30
PMID 36995477
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic coronary syndrome (CCS) is common among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). Current guidelines recommend performance of percutaneous coronary intervention (PCI) of any > 70% proximal coronary lesions prior to TAVI.

Aims: To evaluate the outcomes of two diagnostic approaches for CCS clearance pre-TAVI and to determine the reduction in the need of invasive angiography (IA).

Methods: We investigated 2219 patients undergoing TAVI for severe aortic stenosis at two large centers with different pre-procedural strategies for CCS assessment: pre-TAVI computed tomography angiography (CTA) with selective invasive angiography according to CTA results or mandatory IA. We preformed propensity score matching analysis using a 1:1 ratio. The final study cohort included 870 matched patients. Peri-procedural complications were documented according to the VARC-2 criteria. Mortality rates were prospectively documented.

Results: Mean age of the study population was 82 ± 7, of whom 55% were female. Patients in the IA group had significantly higher rates of pre-TAVI PCI compared to the CTA group (39% vs. 22%, p < 0.001). Following TAVI, peri-procedural myocardial infarction (MI) rates were similar between the two groups (0.3% vs. 0.7%, p value = 0.41), but spontaneous MI were significantly lower among the IA group (0% vs. 1.3%, p value = 0.03). Kaplan-Meier's survival analysis found that the cumulative probability of 1-year morality was similar between the two groups (p value log rank = 0.65). Cox regression analysis did not find association between CCS clearance strategy and outcome.

Conclusions: In elderly patients, CTA-driven approach for CCS evaluation pre-TAVI is a valid strategy with similar outcome as compared to invasive approach. CTA strategy significantly reduces invasive procedures rates without compromising patient's outcome.

References
1.
Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

2.
Reardon M, Van Mieghem N, Popma J . Surgical or Transcatheter Aortic-Valve Replacement. N Engl J Med. 2017; 377(2):197-198. DOI: 10.1056/NEJMc1706234. View

3.
Afilalo J, Lauck S, Kim D, Lefevre T, Piazza N, Lachapelle K . Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017; 70(6):689-700. DOI: 10.1016/j.jacc.2017.06.024. View

4.
Mullany C, ELVEBACK L, Frye R, Pluth J, Edwards W, Orszulak T . Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol. 1987; 10(1):66-72. DOI: 10.1016/s0735-1097(87)80161-4. View

5.
Lund O, Nielsen T, Pilegaard H, Magnussen K, Knudsen M . The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 1990; 100(3):327-37. View